Here’s how a simple blood test could potentially detect cancers early

2026-03-27 - 00:20

Australian researchers have developed a promising test that can identify early-stage cancers with a simple blood test. (Envato Elements pic) KUALA LUMPUR: Imagine detecting cancer with just a simple blood test, long before symptoms appear. That future may be closer than we think. Researchers in Australia have developed a promising test that can identify early-stage cancers by detecting four key proteins in the bloodstream. The findings, published in Cell Reports Medicine, could mark a major step forward in diagnosis. Our bodies constantly release tiny bubble-like particles called extracellular vesicles: microscopic carriers that travel through the blood, ferrying proteins and genetic material between cells. Think of them as biological “messages in a bottle” – some of which can reveal if something is wrong. Scientists from institutions including the University of Queensland and University of Melbourne analysed these particles and identified a distinct four-protein pattern linked to cancer. Using this signature, they have developed a blood test to detect early warning signs. When trialled on patients with nine different types of cancer, the results were striking: the test distinguished healthy individuals from cancer patients with high accuracy. In a smaller group of 68 patients assessed for lung cancer, it could also tell the difference between harmless lung changes and early-stage disease – a distinction that often requires invasive procedures. Why this matters Early detection remains one of the biggest challenges in cancer care, as many cancers are only diagnosed after symptoms appear, and often when the disease has already progressed. This approach, known as a “liquid biopsy”, looks for signs of disease in bodily fluids rather than tissue samples. Compared to traditional biopsies, it reduces the need for invasive procedures and can be repeated over time to monitor changes. As such, a blood test like this could make screening faster, more accessible, and less invasive. While the results are promising, more large-scale studies are needed before the test can be widely used. Still, in the fight against cancer, timing is everything – and these four proteins could make all the difference.